A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population.

Suh, Guk-Hee; Yeon Jung, Hee; Uk Lee, Chang; Hoon Oh, Byoung; Nam Bae, Jae; Jung, Han-Yong; Ju, Young-Su; Kil Yeon, Byeong; Park, Jonghan; Hong, Inja; Choi, Sungku; Ho Lee, Jung

Suh, Guk-Hee; Yeon Jung, Hee; Uk Lee, Chang; Hoon Oh, Byoung; Nam Bae, Jae; Jung, Han-Yong; Ju, Young-Su; Kil Yeon, Byeong; Park, Jonghan; Hong, Inja; Choi, Sungku; Ho Lee, Jung.

Affiliation

Suh GH; Department of Psychiatry, Hallym University College of Medicine, Seoul, Korea. suhgh@chollian.net

Clin Ther ; 26(10): 1608-18, 2004 Oct.

Article in En | MEDLINE | ID: mdl-15598477

Subject(s)

Alzheimer Disease/drug therapy; Galantamine/administration & dosage; Nootropic Agents/administration & dosage; Aged; Asian People; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Galantamine/adverse effects; Humans; Korea; Male; Neuropsychological Tests; Nootropic Agents/adverse effects; Prospective Studies; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Nootropic Agents / Alzheimer Disease / Galantamine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2004 Type: Article

Search on Google

XML

PubMed Links